Page 2 - Australian (ASX) Pharmaceuticals & Biotech Stocks - Biggest Losers Today

UPDATED Nov 23, 2024

Explore the Australian (ASX) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

85 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

EPN

Epsilon Healthcare
AU$0.0240%20.0%AU$7.2mn/aPB0.8xn/an/a

1AI

Algorae Pharmaceuticals
AU$0.0070%-41.7%AU$11.8mn/aPS94.3xn/an/a

1AD

AdAlta
AU$0.0190%-9.5%AU$11.5mn/aPS6.6xn/an/a

CYP

Cynata Therapeutics
AU$0.210%79.2%AU$38.8mAU$1.24PS16.8xE34.1%n/a

CAN

Cann Group
AU$0.0460%-58.2%AU$21.6mn/aPS1.2xn/an/a

VBS

Vectus Biosystems
AU$0.080%-74.6%AU$4.3mn/aPS3.7xn/an/a

SPL

Starpharma Holdings
AU$0.120%-17.9%AU$48.0mn/aPS4.9xn/an/a

ZLD

Zelira Therapeutics
AU$0.640%-37.3%AU$7.3mn/aPS76.5xn/an/a

CHM

Chimeric Therapeutics
AU$0.0090%-71.0%AU$8.1mn/aPS1.1xn/an/a

ECS

ECS Botanics Holdings
AU$0.0170%-29.2%AU$21.9mn/aPE11.4xn/an/a

CMB

Cambium Bio
AU$0.520%n/aAU$6.2mn/an/an/an/a

EOF

Ecofibre
AU$0.0420%-68.9%AU$15.4mn/aPB0.4xn/an/a

WFL

Wellfully
AU$0.0030%-87.0%AU$1.5mn/aPE-0.2xn/an/a

VIT

Vitura Health
AU$0.0980%-68.9%AU$57.0mn/aPE16.2xn/a0%

IMC

Immuron
AU$0.0750%-1.3%AU$17.2mn/aPS3.5xE22.4%n/a

IDT

IDT Australia
AU$0.100%7.5%AU$43.0mn/aPS3.1xn/an/a

NUZ

Neurizon Therapeutics
AU$0.190%131.7%AU$92.5mn/aPS109.8xS58.2%n/a

ILA

Island Pharmaceuticals
AU$0.170%106.3%AU$25.7mn/aPS20.6xE4.1%n/a

CGB

Cann Global
AU$0.0210%-72.0%AU$5.4mn/aPS9.7xn/an/a

NC6

Nanollose
AU$0.0170%-22.7%AU$2.9mn/aPS9.6xn/an/a

HXL

Hexima
AU$0.0130%n/aAU$2.2mn/aPS35.2xn/an/a

BIT

Biotron
AU$0.0190%-81.0%AU$17.1mn/aPS10.4xn/an/a

IXC

Invex Therapeutics
AU$0.0760%-67.7%AU$5.7mn/aPS4.7xn/a245.1%

RNO

Rhinomed
AU$0.040%-55.6%AU$11.5mn/aPS1.4xn/an/a
Page 2 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.